Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients

被引：0
|
作者：
Kana Akiyama
Tetsuo Kume
Masafumi Fukaya
Ikue Shiki
Terukazu Enami
Raine Tatara
Michihiro Shino
Takashi Ikeda
机构：
[1] Shizuoka Cancer Center,Department of Pharmacy
[2] Shizuoka Cancer Center,Division of Hematology and Stem Cell Transplantation
来源：
Cancer Chemotherapy and Pharmacology | 2018年 / 82卷
关键词：
Anticonvulsant; Intravenous busulfan; Seizures; Stem cell transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：717 / 721
页数：4
相关论文
共 50 条
  • [31] Association Between Busulfan Exposure and Outcome in Children Receiving Intravenous Busulfan Before Hematopoietic Stem Cell Transplantation
    Ansari, Marc
    Theoret, Yves
    Rezgui, Mohamed Aziz
    Peters, Christina
    Mezziani, Samira
    Desjean, Catherine
    Vachon, Marie-France
    Champagne, Martin A.
    Duval, Michel
    Krajinovic, Maja
    Bittencourt, Henrique
    THERAPEUTIC DRUG MONITORING, 2014, 36 (01) : 93 - 99
  • [32] Limited sampling strategy for predicting busulfan exposure in hematopoietic stem cell transplantation recipients
    Jing-jing Huang
    Bing Chen
    Jiong Hu
    Wan-Hua Yang
    International Journal of Clinical Pharmacy, 2017, 39 : 662 - 668
  • [33] RETROSPECTIVE COMPARISON OF PHENYTOIN AND LEVETIRACETAM AS SEIZURE PROPHYLAXIS WITH HIGH DOSE BUSULFAN DURING ALLOGENEIC STEM CELL TRANSPLANT
    Mathew, S.
    Harnicar, S.
    Adel, N.
    Papadopoulos, E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S353 - S353
  • [34] Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients
    Malaer, Reta
    Sjoo, Fredrik
    Rentsch, Katharina
    Hassan, Moustapha
    Guengoer, Tayfun
    PEDIATRIC TRANSPLANTATION, 2011, 15 (06) : 580 - 588
  • [35] Intravenous busulfan: In the conditioning treatment of pediatric patients prior to hematopoietic stem cell transplantation
    Hoy S.M.
    Lyseng-Williamson K.A.
    Pediatric Drugs, 2007, 9 (4) : 271 - 278
  • [36] Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children
    Okamoto, Yasuhiro
    Nagatoshi, Yoshihisa
    Kosaka, Yoshiyuki
    Kikuchi, Akira
    Kato, Shunichi
    Kigasawa, Hisato
    Horikoshi, Yasuo
    Oda, Megumi
    Kaneda, Makoto
    Mori, Tetsuya
    Mugishima, Hideo
    Tsuchida, Masahiro
    Taniguchi, Shuichi
    Kawano, Yoshifumi
    PEDIATRIC TRANSPLANTATION, 2014, 18 (03) : 294 - 301
  • [37] Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results
    Dalle, JH
    Wall, D
    Theoret, Y
    Duval, M
    Shaw, L
    Larocque, D
    Taylor, C
    Gardiner, J
    Vachon, MF
    Champagne, MA
    BONE MARROW TRANSPLANTATION, 2003, 32 (07) : 647 - 651
  • [38] Generic Intravenous Busulfan in Hematopoietic Stem Cell Transplantation: Relevance of Therapeutic Drug Monitoring
    Mohanan, Ezhil Pavai
    Royan, Shareen Stella Backia
    Panetta, John C.
    Abubacker, Fouzia Nambiathayil
    Korula, Anu
    Abraham, Aby
    Viswabandya, Auro
    George, Biju
    Srivastava, Alok
    Mathews, Vikram
    Balasubramanian, Poonkuzhali
    BLOOD, 2015, 126 (23)
  • [39] Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results
    J H Dalle
    D Wall
    Y Theoret
    M Duval
    L Shaw
    D Larocque
    C Taylor
    J Gardiner
    M F Vachon
    M A Champagne
    Bone Marrow Transplantation, 2003, 32 : 647 - 651
  • [40] PHARMACOKINETICS OF ONCE-DAILY INTRAVENOUS BUSULFAN IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Utano, Tomoyuki
    Sakaguchi, Hirotoshi
    Gocho, Yoshihiro
    Osumi, Tomoo
    Iguchi, Akihiro
    Tomizawa, Daisuke
    Matsumoto, Kimikazu
    Matsumoto, Kana
    Kato, Motohiro
    Yamatani, Akimasa
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S28 - S28
12345